Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

To evaluate the efficacy of Molnupiravir to standard of care in confirmed RT-PCR positive patients with Mild COVID-19Timepoint: Day 1 to Day 5 <br/ > <br/ >RT-PCR will be evaluated on screening; end of treatment day (plus 1) or at the time of early discontinuation. <br/ > <br/ >Note: If RT-PCR test is found to be positive for Day 5 (plus 1) sample; the test may be repeated on Day 10 and on Day 14; if it was positive on Day 10 <br/ > <br/ >Post treatment follow-up Day 10; Day 14(plus 1 Day); 28 Day ( plus 1 Day) <br/ > <br/ >Rate of hospitalization from randomization up to day 14

To evaluate the efficacy of Molnupiravir to standard of care in confirmed RT-PCR positive patients with Mild COVID-19Timepoint: Day 1 to Day 5 <br/ > <br/ >RT-PCR will be evaluated on screening; end of treatment day (plus 1) or at the time of early discontinuation. <br/ > <br/ >Note: If RT-PCR test is found to be positive for Day 5 (plus 1) sample; the test may be repeated on Day 10 and on Day 14; if it was positive on Day 10 <br/ > <br/ >Post treatment follow-up Day 10; Day 14(plus 1 Day); 28 Day ( plus 1 Day) <br/ > <br/ >Rate of hospitalization from randomization up to day 14

Nov. 13, 2021, 5:33 p.m. oms

N/A

N/A

Sept. 8, 2021, 1:30 a.m. oms

To evaluate the efficacy of Molnupiravir to standard of care in confirmed RT-PCR positive patients with Mild COVID-19Timepoint: Day 1 to Day 5 <br/ > <br/ >RT-PCR will be evaluated on screening; end of treatment day (plus 1) or at the time of early discontinuation. <br/ > <br/ >Note: If RT-PCR test is found to be positive for Day 5 (plus 1) sample; the test may be repeated on Day 10 and on Day 14; if it was positive on Day 10 <br/ > <br/ >Post treatment follow-up Day 10; Day 14(plus 1 Day); 28 Day ( plus 1 Day) <br/ > <br/ >Rate of hospitalization from randomization up to day 14

To evaluate the efficacy of Molnupiravir to standard of care in confirmed RT-PCR positive patients with Mild COVID-19Timepoint: Day 1 to Day 5 <br/ > <br/ >RT-PCR will be evaluated on screening; end of treatment day (plus 1) or at the time of early discontinuation. <br/ > <br/ >Note: If RT-PCR test is found to be positive for Day 5 (plus 1) sample; the test may be repeated on Day 10 and on Day 14; if it was positive on Day 10 <br/ > <br/ >Post treatment follow-up Day 10; Day 14(plus 1 Day); 28 Day ( plus 1 Day) <br/ > <br/ >Rate of hospitalization from randomization up to day 14